05-08-2024 |
PM |
|
AXSM |
Axsome Therapeutics, Inc. |
4,090 |
-1.24 |
-1.30 |
1.00 |
Axsome Therapeutics GAAP EPS of -$1.67 misses by $0.34, revenue of $87.2M beats by $0.27M [8/5/2024 7:01 AM] |
83.18 |
-1.24 (-1.47%) |
75.01 |
-9.41 (-11.15%) |
55.02 - 98.40 |
766,594 |
530,000 |
4,233 |
|
|
06-05-2024 |
PM |
|
AXSM |
Axsome Therapeutics, Inc. |
3,510 |
-1.09 |
-1.20 |
-0.22 |
Axsome Therapeutics GAAP EPS of -$1.44 misses by $0.21, revenue of $75M beats by $2.15M [5/6/2024 7:01 AM] |
75.86 |
1.06 (1.42%) |
74.75 |
-0.05 (-0.07%) |
55.02 - 98.40 |
726,095 |
500,000 |
5,712 |
|
|
20-02-2024 |
PM |
|
AXSM |
Axsome Therapeutics, Inc. |
4,420 |
-0.73 |
-1.21 |
-1.28 |
Axsome Therapeutics GAAP EPS of -$2.08 misses by $0.92, revenue of $71.53M beats by $2.49M [2/20/2024 7:10 AM] |
81.42 |
-11.39 (-12.28%) |
85.40 |
-7.41 (-7.98%) |
53.71 - 98.40 |
2,824,374 |
560,000 |
28,315 |
|
|
06-11-2023 |
PM |
|
AXSM |
Axsome Therapeutics, Inc. |
3,040 |
-1.32 |
-1.24 |
-1.03 |
Axsome Therapeutics GAAP EPS of -$1.32 misses by $0.09, revenue of $57.79M beats by $2.93M [11/6/2023 7:02 AM] |
62.50 |
-2.64 (-4.05%) |
62.42 |
-0.08 (-0.13%) |
49.60 - 91.29 |
1,211,820 |
680,000 |
2,522 |
|
|
07-08-2023 |
PM |
|
AXSM |
Axsome Therapeutics, Inc. |
3,280 |
-1.00 |
-1.24 |
-1.06 |
Axsome Therapeutics GAAP EPS of -$1.54 misses by $0.30, revenue of $46.01M beats by $5.06M [8/7/2023 7:01 AM] |
71.09 |
-2.57 (-3.49%) |
75.25 |
1.59 (2.16%) |
38.87 - 91.29 |
1,754,395 |
750,000 |
55,908 |
|
|
08-05-2023 |
PM |
7:00 AM ET (May 8) |
AXSM |
Axsome Therapeutics, Inc. |
3,100 |
-0.22 |
-1.13 |
-1.03 |
Axsome TherapeuticsEPS of -$0.26, revenue of $94.6M beats by $69.12M [5/8/2023 7:03 AM] |
77.20 |
3.46 (4.69%) |
77.65 |
3.91 (5.30%) |
20.63 - 82.85 |
2,626,732 |
570,000 |
58,020 |
|
|
27-02-2023 |
PM |
7:00 AM ET (Feb 27) |
AXSM |
Axsome Therapeutics, Inc. |
2,720 |
-1.28 |
-1.18 |
-0.90 |
Axsome Therapeutics GAAP EPS of -$1.41 misses by $0.28, revenue of $24.37M beats by $2.49M [2/27/2023 7:02 AM] |
64.06 |
3.02 (4.94%) |
63.80 |
2.75 (4.50%) |
20.63 - 82.00 |
1,468,166 |
930,000 |
42,181 |
|
|
07-11-2022 |
PM |
7:00 AM ET (Nov 7) |
AXSM |
Axsome Therapeutics, Inc. |
2,590 |
-1.03 |
-1.10 |
-0.93 |
Axsome Therapeutics GAAP EPS of -$1.07 beats by $0.02, revenue of $16.8M misses by $0.26M [11/7/2022 7:03 AM] |
56.76 |
-0.33 (-0.58%) |
54.53 |
-2.56 (-4.48%) |
20.63 - 71.98 |
1,022,832 |
1,530,000 |
23,010 |
|
|
09-08-2022 |
PM |
7:05 AM ET (Aug 9) |
AXSM |
Axsome Therapeutics, Inc. |
1,570 |
-1.06 |
-1.19 |
-0.86 |
Axsome Therapeutics GAAP EPS of -$1.06 beats by $0.18, revenue of $8.81M beats by $2.52M [8/9/2022 7:03 AM] |
44.98 |
1.67 (3.86%) |
40.20 |
-3.11 (-7.18%) |
19.38 - 47.49 |
1,473,885 |
710,000 |
53,317 |
|
|
02-05-2022 |
PM |
7:00 AM ET (May 2) |
AXSM |
Axsome Therapeutics, Inc. |
1,250 |
-1.03 |
-1.02 |
-0.78 |
Axsome Therapeutics GAAP EPS of -$1.03 misses by $0.03 [5/2/2022 7:09 AM] |
34.09 |
2.34 (7.38%) |
31.59 |
-0.16 (-0.50%) |
19.38 - 74.10 |
1,129,801 |
2,420,000 |
81,599 |
|
|
01-03-2022 |
PM |
7:00 AM ET (Mar 1) |
AXSM |
Axsome Therapeutics, Inc. |
1,060 |
-0.90 |
-0.99 |
-0.78 |
Axsome Therapeutics GAAP EPS of -$0.90 beats by $0.08 [3/1/2022 7:03 AM] |
30.85 |
2.74 (9.75%) |
28.24 |
0.13 (0.46%) |
19.38 - 74.10 |
1,315,397 |
620,000 |
93,587 |
|
|
08-11-2021 |
PM |
7:05 AM ET (Nov 8) |
AXSM |
Axsome Therapeutics, Inc. |
1,540 |
-0.93 |
-0.94 |
-0.58 |
Axsome Therapeutics EPS beats by $0.03 [11/8/2021 7:03 AM] |
43.35 |
3.15 (7.84%) |
39.27 |
-0.93 (-2.31%) |
19.38 - 87.24 |
1,558,082 |
620,000 |
153,436 |
|
|
09-08-2021 |
PM |
7:00 AM ET (Aug 9) |
AXSM |
Axsome Therapeutics, Inc. |
1,830 |
-0.86 |
-0.88 |
-0.49 |
Axsome Therapeutics EPS beats by $0.07 [8/9/2021 7:05 AM] |
27.36 |
-23.80 (-46.52%) |
33.10 |
-18.06 (-35.30%) |
27.30 - 90.00 |
9,128,010 |
340,000 |
1,558,545 |
|
|
10-05-2021 |
PM |
7:00 AM ET (May 10) |
AXSM |
Axsome Therapeutics, Inc. |
2,310 |
-0.78 |
-0.83 |
-0.88 |
Axsome Therapeutics EPS beats by $0.04 [5/10/2021 7:05 AM] |
54.04 |
-2.92 (-5.13%) |
58.64 |
1.68 (2.95%) |
50.05 - 94.06 |
320,297 |
590,000 |
644 |
|
|
01-03-2021 |
PM |
7:00 AM ET (Mar 1) |
AXSM |
Axsome Therapeutics, Inc. |
2,700 |
-0.78 |
-0.73 |
-0.71 |
Axsome Therapeutics EPS misses by $0.08 [3/1/2021 7:02 AM] |
69.09 |
1.73 (2.57%) |
67.36 |
0.0 (0.00%) |
35.44 - 109.53 |
415,318 |
293,066 |
8,519 |
|
|
05-11-2020 |
PM |
7:05 AM ET (Nov 5) |
AXSM |
Axsome Therapeutics, Inc. |
2,590 |
-0.58 |
-0.58 |
-0.56 |
Axsome Therapeutics EPS misses by $0.03 [11/5/2020 7:18 AM] |
69.51 |
-5.22 (-6.99%) |
69.51 |
0.0 (0.00%) |
20.48 - 109.94 |
569,460 |
271,759 |
3,154 |
|
|
10-08-2020 |
PM |
7:00 AM ET (Aug 10) |
AXSM |
Axsome Therapeutics, Inc. |
2,890 |
-0.49 |
-0.54 |
-0.41 |
Axsome Therapeutics EPS beats by $0.12 [8/10/2020 7:08 AM] |
82.11 |
4.04 (5.17%) |
80.96 |
2.89 (3.70%) |
13.64 - 109.94 |
277,507 |
373,825 |
3,162 |
|
|